secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0001558370-23-001038
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Animal Health Q2 net income down 59% to $7.2M; guidance lowered on environmental costs
--------------------------------------------------------------------------------

- Net sales $244.6M (+5% YoY); GAAP diluted EPS $0.18 vs $0.43 prior; adjusted diluted EPS $0.34 vs $0.37.
- Adjusted EBITDA $30.9M (+6% YoY); Animal Health segment grew 9% while Mineral Nutrition declined 8%.
- Recorded $6.6M environmental remediation cost from tentative settlement of California contamination lawsuit.
- Updated FY23 guidance: Net income lowered to $34-38M (from $39-43M); adjusted metrics unchanged.
- Free cash flow -$45M over trailing 12 months due to inventory build to mitigate supply chain risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/0001558370-23-001038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/pahc-20230208x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-001038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer